JP2024516392A5 - - Google Patents
Info
- Publication number
- JP2024516392A5 JP2024516392A5 JP2023565419A JP2023565419A JP2024516392A5 JP 2024516392 A5 JP2024516392 A5 JP 2024516392A5 JP 2023565419 A JP2023565419 A JP 2023565419A JP 2023565419 A JP2023565419 A JP 2023565419A JP 2024516392 A5 JP2024516392 A5 JP 2024516392A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- human
- molecule
- oligomer
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163180969P | 2021-04-28 | 2021-04-28 | |
| US63/180,969 | 2021-04-28 | ||
| PCT/US2022/026505 WO2022232246A1 (en) | 2021-04-28 | 2022-04-27 | Multimerization of binding molecules having an antibody constant region variant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516392A JP2024516392A (ja) | 2024-04-15 |
| JP2024516392A5 true JP2024516392A5 (enExample) | 2025-05-02 |
Family
ID=83847261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565419A Withdrawn JP2024516392A (ja) | 2021-04-28 | 2022-04-27 | 抗体定常領域バリアントを有する結合分子の多量体化 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240209116A1 (enExample) |
| EP (1) | EP4330277A4 (enExample) |
| JP (1) | JP2024516392A (enExample) |
| CN (2) | CN117255800A (enExample) |
| AU (1) | AU2022266780A1 (enExample) |
| CA (1) | CA3216755A1 (enExample) |
| WO (1) | WO2022232246A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4206226A4 (en) * | 2020-08-31 | 2024-10-16 | Medytox Inc. | Anti-vegf hexameric antibody and composition comprising same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6509724B2 (ja) * | 2012-04-20 | 2019-05-08 | アプティーボ リサーチ アンド デベロップメント エルエルシー | Ｃｄ３結合ポリペプチド |
| CN104736174B (zh) * | 2012-07-06 | 2019-06-14 | 根马布私人有限公司 | 具有三重突变的二聚体蛋白质 |
| JP2015524821A (ja) * | 2012-08-02 | 2015-08-27 | ジェイエヌ バイオサイエンシーズ エルエルシー | システイン変異及びμ尾部を介して多量体化した抗体又は融合タンパク質 |
| JP6685924B2 (ja) * | 2014-04-11 | 2020-04-22 | メディミューン，エルエルシー | システイン操作抗体を含むコンジュゲート化合物 |
| KR20180002653A (ko) * | 2015-04-07 | 2018-01-08 | 제넨테크, 인크. | 효능작용 활성을 갖는 항원 결합 복합체 및 사용 방법 |
-
2022
- 2022-04-27 EP EP22796621.5A patent/EP4330277A4/en not_active Withdrawn
- 2022-04-27 WO PCT/US2022/026505 patent/WO2022232246A1/en not_active Ceased
- 2022-04-27 CA CA3216755A patent/CA3216755A1/en active Pending
- 2022-04-27 AU AU2022266780A patent/AU2022266780A1/en not_active Abandoned
- 2022-04-27 JP JP2023565419A patent/JP2024516392A/ja not_active Withdrawn
- 2022-04-27 CN CN202280030416.0A patent/CN117255800A/zh active Pending
- 2022-04-27 CN CN202410422718.3A patent/CN118359707A/zh active Pending
- 2022-04-27 US US18/557,273 patent/US20240209116A1/en active Pending